ASAP3 and osteosarcoma: We individually depleted ASAP1, ASAP2, or ASAP3 in U2OS human osteosarcoma cells using SMARTpool siRNAs, replated the cells on fibronectin in serum-free media, stained the cells with fluorescent phalloidin, and examined them using laser scanning confocal microscopy.